NKTR Deadline: Rosen Law Firm Urges Nektar Therapeutics (NASDAQ: NKTR) Stockholders to Contact the Firm for Information About Their RightsApril 27, 2026
Share Twitter Facebook LinkedIn Email A July 20 memo ordered U.S. intelligence agencies not to share information about Russia-Ukraine talks with Five Eyes partners U.K., Canada, Australia and New Zealand.Read More